Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphedema 1Lung Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 104Specimen Handling 76Magnetic Resonance Spectroscopy 66Cisplatin 63Carboplatin 63Biopsy 58Nivolumab 51Cyclophosphamide 47Radiotherapy 45Paclitaxel 43Gemcitabine 37durvalumab 34Radiation 33Rituximab 32Dexamethasone 30olaparib 29Docetaxel 28Doxorubicin 27Etoposide 26atezolizumab 25Ipilimumab 25Lenalidomide 24Bevacizumab 24Taxes 23Pemetrexed 23Vincristine 22Prednisone 22Platinum 22Leucovorin 22Radiotherapy, Intensity-Modulated 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Methods × 90 days × Clear all
NCT00376597 2026-05-18

Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection

Alliance for Clinical Trials in Oncology

Phase 3 Completed
568 enrolled 7 charts
Breast

Breast Neoplasms, Lymphedema

NCT04905082 2026-03-24

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

City of Hope Medical Center

Phase NA Active not recruiting
465 enrolled 11 charts
BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡